Melamine Update

FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination

2009-08-19, 12:00

In a recent guidance issued by the U.S. Food and Drug Administration, it says that certain pharmaceutical ingredients used in the manufacture or preparation of drug products are recommended to be screened for melamine.

"The FDA urges implementation of appropriate controls to assure consumers that melamine contamination will not happen in the pharmaceutical supply chain," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "We look forward to working with industry on this serious public health concern."

Merck SeQuant provides more information on this topic and methods for melamine analysis.

[ZIC®-HILIC »]     [What is HILIC? »]     [Melamine Analysis »]

 

 

 



[News Archive]